Cargando…

Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation

INTRODUCTION: Increased intestinal hydration by activation of the epithelial enzyme linked receptor guanylate cyclase C (GC-C) is a pharmacological principle for treating constipation. Activating mutations in the GUCY2C gene encoding GC-C cause Familial GUCY2C diarrhea syndrome (FGDS) which has been...

Descripción completa

Detalles Bibliográficos
Autores principales: von Volkmann, Hilde L., Brønstad, Ingeborg, Gilja, Odd Helge, R. Tronstad, Rune, Sangnes, Dag Andre, Nortvedt, Ragnar, Hausken, Trygve, Dimcevski, Georg, Fiskerstrand, Torunn, Nylund, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619782/
https://www.ncbi.nlm.nih.gov/pubmed/28957388
http://dx.doi.org/10.1371/journal.pone.0185496
_version_ 1783267465035251712
author von Volkmann, Hilde L.
Brønstad, Ingeborg
Gilja, Odd Helge
R. Tronstad, Rune
Sangnes, Dag Andre
Nortvedt, Ragnar
Hausken, Trygve
Dimcevski, Georg
Fiskerstrand, Torunn
Nylund, Kim
author_facet von Volkmann, Hilde L.
Brønstad, Ingeborg
Gilja, Odd Helge
R. Tronstad, Rune
Sangnes, Dag Andre
Nortvedt, Ragnar
Hausken, Trygve
Dimcevski, Georg
Fiskerstrand, Torunn
Nylund, Kim
author_sort von Volkmann, Hilde L.
collection PubMed
description INTRODUCTION: Increased intestinal hydration by activation of the epithelial enzyme linked receptor guanylate cyclase C (GC-C) is a pharmacological principle for treating constipation. Activating mutations in the GUCY2C gene encoding GC-C cause Familial GUCY2C diarrhea syndrome (FGDS) which has been diagnosed with severe dysmotility. AIM: To investigate gut motility and hormones before and after a meal in FGDS patients and compare with healthy controls (HC). SUBJECTS AND METHODS: Bristol stool chart and stool frequency was assessed. Before and after a meal occlusive and non-occlusive contractions were obtained using ultrasound. A wireless motility capsule (WMC) recorded gut transit time, pH, contractions and pressure. Plasma levels of selected gut hormones were measured at different time points. RESULTS: The FGDS patients had 4 (range 1–10) loose stools/day and prolonged total gut transit time compared to HC, 55.5 h vs 28.5 h, respectively,with significantly increased colon transit time. In FGDS patients, pH in duodenum, small bowel and colon was increased and the number of contractions and the intraluminal pressure were significantly decreased, measured by WMC. Ultrasound showed in small bowel increased number of non-occlusive contractions in the FGDS patients. Serotonin (5-HT) plasma levels in the HC peaked 30 min after the meal, while the FGDS patients had no response. CONCLUSION: Despite having diarrhea, the FGDS patients have prolonged transit time through the gut compared to HC, particularly in colon. The reduced number of intestinal contractions and lack of 5-HT release after a meal in FGDS patients surprisingly resemble colonic motility disturbances seen in patients with constipation.
format Online
Article
Text
id pubmed-5619782
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56197822017-10-17 Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation von Volkmann, Hilde L. Brønstad, Ingeborg Gilja, Odd Helge R. Tronstad, Rune Sangnes, Dag Andre Nortvedt, Ragnar Hausken, Trygve Dimcevski, Georg Fiskerstrand, Torunn Nylund, Kim PLoS One Research Article INTRODUCTION: Increased intestinal hydration by activation of the epithelial enzyme linked receptor guanylate cyclase C (GC-C) is a pharmacological principle for treating constipation. Activating mutations in the GUCY2C gene encoding GC-C cause Familial GUCY2C diarrhea syndrome (FGDS) which has been diagnosed with severe dysmotility. AIM: To investigate gut motility and hormones before and after a meal in FGDS patients and compare with healthy controls (HC). SUBJECTS AND METHODS: Bristol stool chart and stool frequency was assessed. Before and after a meal occlusive and non-occlusive contractions were obtained using ultrasound. A wireless motility capsule (WMC) recorded gut transit time, pH, contractions and pressure. Plasma levels of selected gut hormones were measured at different time points. RESULTS: The FGDS patients had 4 (range 1–10) loose stools/day and prolonged total gut transit time compared to HC, 55.5 h vs 28.5 h, respectively,with significantly increased colon transit time. In FGDS patients, pH in duodenum, small bowel and colon was increased and the number of contractions and the intraluminal pressure were significantly decreased, measured by WMC. Ultrasound showed in small bowel increased number of non-occlusive contractions in the FGDS patients. Serotonin (5-HT) plasma levels in the HC peaked 30 min after the meal, while the FGDS patients had no response. CONCLUSION: Despite having diarrhea, the FGDS patients have prolonged transit time through the gut compared to HC, particularly in colon. The reduced number of intestinal contractions and lack of 5-HT release after a meal in FGDS patients surprisingly resemble colonic motility disturbances seen in patients with constipation. Public Library of Science 2017-09-28 /pmc/articles/PMC5619782/ /pubmed/28957388 http://dx.doi.org/10.1371/journal.pone.0185496 Text en © 2017 von Volkmann et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
von Volkmann, Hilde L.
Brønstad, Ingeborg
Gilja, Odd Helge
R. Tronstad, Rune
Sangnes, Dag Andre
Nortvedt, Ragnar
Hausken, Trygve
Dimcevski, Georg
Fiskerstrand, Torunn
Nylund, Kim
Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation
title Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation
title_full Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation
title_fullStr Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation
title_full_unstemmed Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation
title_short Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation
title_sort prolonged intestinal transit and diarrhea in patients with an activating gucy2c mutation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619782/
https://www.ncbi.nlm.nih.gov/pubmed/28957388
http://dx.doi.org/10.1371/journal.pone.0185496
work_keys_str_mv AT vonvolkmannhildel prolongedintestinaltransitanddiarrheainpatientswithanactivatinggucy2cmutation
AT brønstadingeborg prolongedintestinaltransitanddiarrheainpatientswithanactivatinggucy2cmutation
AT giljaoddhelge prolongedintestinaltransitanddiarrheainpatientswithanactivatinggucy2cmutation
AT rtronstadrune prolongedintestinaltransitanddiarrheainpatientswithanactivatinggucy2cmutation
AT sangnesdagandre prolongedintestinaltransitanddiarrheainpatientswithanactivatinggucy2cmutation
AT nortvedtragnar prolongedintestinaltransitanddiarrheainpatientswithanactivatinggucy2cmutation
AT hauskentrygve prolongedintestinaltransitanddiarrheainpatientswithanactivatinggucy2cmutation
AT dimcevskigeorg prolongedintestinaltransitanddiarrheainpatientswithanactivatinggucy2cmutation
AT fiskerstrandtorunn prolongedintestinaltransitanddiarrheainpatientswithanactivatinggucy2cmutation
AT nylundkim prolongedintestinaltransitanddiarrheainpatientswithanactivatinggucy2cmutation